|
|
For the Year Ending |
|
|
Financial Statements |
Page |
|
Trustees' Annual Report (Incorporating the Director's Report) |
1 |
Independent Examiner's Report to the Trustees |
6 |
Statement of Financial Activities (Including Income and Expenditure Account) |
7 |
Statement of Financial Position |
8 |
Notes to the Financial Statements |
9 |
|
Trustees' Annual Report (Incorporating the Director's Report) |
Registered charity name |
|
Charity registration number |
|
Company registration number |
|
Principal office and registered |
C/o Citizens Advice Carlisle and Eden Office |
office |
2 Sandgate |
Penrith |
|
Cumbria |
|
CA11 7TP |
|
|
||
|
||
A J Setters Chair (Appointed 7 November 2023) J Whitehead Citizens Advice South Lakes (Resigned 23 October 2023) G P Smith Citizens Advice Copeland (Treasurer) J A Auld Citizens Advice Carlisle & Eden D Shepherd Citizens Advice Carlisle & Eden (Resigned 31 May 2023) M C McKinlay Citizens Advice Barrow In Furness K Evans Citizens Advice South Lakes K A Little Citizens Advice Allerdale W Robinson Citizens Advice Barrow In Furness (Resigned 16 January 2024) S Hewitson Citizens Advice Copeland T F Edwards Citizens Advice Allerdale |
|
Company Secretary |
|
Independent Examiner |
|
Enterprise House |
|
Harmire Enterprise Park |
|
Barnard Castle |
|
County Durham |
|
DL12 8XP |
|
|
Trustee |
|
Independent Examiner's Report to the Trustees of
|
|
Statement of Financial Activities |
(including income and expenditure account) |
2024 |
2023 |
|||
Unrestricted funds |
Restricted funds |
Total funds |
Total funds |
|
Note |
£ |
£ |
£ |
£ |
Charitable activities |
5 |
– |
|
|
|
Investment income |
6 |
|
– |
|
|
Other income |
7 |
|
– |
|
– |
------- |
--------- |
--------- |
--------- |
||
Total income |
|
|
|
|
|
------- |
--------- |
--------- |
--------- |
||
Expenditure on charitable activities |
8,9 |
|
|
|
|
------- |
--------- |
--------- |
--------- |
||
Total expenditure |
|
|
|
|
|
------- |
--------- |
--------- |
--------- |
||
------- |
--------- |
--------- |
--------- |
|
Net income/(expenditure) |
(
|
|
|
(
|
------- |
--------- |
--------- |
--------- |
|
Transfers between funds |
2,426 |
(2,426) |
– |
– |
------- |
--------- |
--------- |
--------- |
|
Net movement in funds |
|
– |
|
(
|
Total funds brought forward |
|
– |
|
|
-------- |
--------- |
--------- |
--------- |
|
Total funds carried forward |
|
– |
|
|
-------- |
--------- |
--------- |
--------- |
|
|
Statement of Financial Position |
2024 |
2023 |
|
Note |
£ |
£ |
Debtors |
15 |
|
|
Cash at bank and in hand |
|
|
|
-------- |
-------- |
||
|
|
||
Creditors: amounts falling due within one year |
16 |
|
|
-------- |
-------- |
||
Net Current Assets |
|
|
|
-------- |
-------- |
||
Total Assets Less Current Liabilities |
|
|
|
-------- |
-------- |
||
Net Assets |
|
|
|
-------- |
-------- |
||
Unrestricted funds |
|
|
|
-------- |
-------- |
||
Total charity funds |
17 |
|
|
-------- |
-------- |
||
|
Trustee |
|
Notes to the Financial Statements |
Equipment |
- |
Fully depreciated
|
|
Restricted Funds |
Total Funds 2024 |
Restricted Funds |
Total Funds 2023 |
||
£ |
£ |
£ |
£ |
||
Macmillan Cancer Support |
|
|
|
|
|
--------- |
--------- |
--------- |
--------- |
||
Unrestricted Funds |
Total Funds 2024 |
Unrestricted Funds |
Total Funds 2023 |
||
£ |
£ |
£ |
£ |
||
Bank interest |
|
|
|
|
|
---- |
---- |
---- |
---- |
||
Unrestricted Funds |
Total Funds 2024 |
Unrestricted Funds |
Total Funds 2023 |
||
£ |
£ |
£ |
£ |
||
Training income |
|
|
– |
– |
|
------- |
------- |
---- |
---- |
||
Unrestricted Funds |
Restricted Funds |
Total Funds 2024 |
||
£ |
£ |
£ |
||
Macmillan Cancer Support |
– |
248,722 |
248,722 |
|
LCA Support |
3,883 |
– |
3,883 |
|
Support costs |
1,481 |
– |
1,481 |
|
------- |
--------- |
--------- |
||
|
|
|
||
------- |
--------- |
--------- |
||
Unrestricted Funds |
Restricted Funds |
Total Funds 2023 |
||
£ |
£ |
£ |
||
Macmillan Cancer Support |
– |
203,839 |
203,839 |
|
LCA Support |
2,750 |
– |
2,750 |
|
Support costs |
1,115 |
– |
1,115 |
|
------- |
--------- |
--------- |
||
|
|
|
||
------- |
--------- |
--------- |
||
Activities undertaken directly |
Support costs |
Total funds 2024 |
Total fund 2023 |
||
£ |
£ |
£ |
£ |
||
Macmillan Cancer Support |
248,722 |
– |
248,722 |
203,839 |
|
LCA Support |
3,883 |
– |
3,883 |
2,750 |
|
Governance costs |
– |
1,481 |
1,481 |
1,115 |
|
--------- |
------- |
--------- |
--------- |
||
|
|
|
|
||
--------- |
------- |
--------- |
--------- |
||
2024 |
2023 |
|
£ |
£ |
|
Independent examination of the financial statements |
816 |
780 |
---- |
---- |
|
Equipment |
|
£ |
|
Cost |
|
At 1 April 2023 and 31 March 2024 |
|
------- |
|
Depreciation |
|
At 1 April 2023 and 31 March 2024 |
|
------- |
|
Carrying amount |
|
At 31 March 2024 |
– |
------- |
|
At 31 March 2023 |
– |
------- |
|
2024 |
2023 |
|
£ |
£ |
|
Macmillan debtor |
|
|
-------- |
-------- |
|
2024 |
2023 |
|
£ |
£ |
|
Accruals and deferred income |
|
|
Macmillan partner payments owed to local CitA offices |
|
|
-------- |
-------- |
|
|
|
|
-------- |
-------- |
|
At 1 April 2023 |
Income |
Expenditure |
Transfers |
At 31 March 2024 |
|
£ |
£ |
£ |
£ |
£ |
|
General funds |
13,052 |
3,412 |
(5,364) |
2,426 |
13,526 |
Designated Funds |
14,000 |
– |
– |
– |
14,000 |
-------- |
------- |
------- |
------- |
-------- |
|
27,052 |
3,412 |
(5,364) |
2,426 |
27,526 |
|
-------- |
------- |
------- |
------- |
-------- |
|
At 1 April 2022 |
Income |
Expenditure |
Transfers |
At 31 March 2023 |
|
£ |
£ |
£ |
£ |
£ |
|
General funds |
14,610 |
135 |
(3,865) |
2,172 |
13,052 |
Designated Funds |
14,000 |
– |
– |
– |
14,000 |
-------- |
---- |
------- |
------- |
-------- |
|
28,610 |
135 |
(3,865) |
2,172 |
27,052 |
|
-------- |
---- |
------- |
------- |
-------- |
|
At 1 April 2023 |
Income |
Expenditure |
Transfers |
At 31 March 2024 |
|
£ |
£ |
£ |
£ |
£ |
|
MacMillan Cancer Support |
– |
251,148 |
(248,722) |
(2,426) |
– |
---- |
--------- |
--------- |
------- |
---- |
|
At 1 April 2022 |
Income |
Expenditure |
Transfers |
At 31 March 2023 |
|
£ |
£ |
£ |
£ |
£ |
|
MacMillan Cancer Support |
– |
206,011 |
(203,839) |
(2,172) |
– |
---- |
--------- |
--------- |
------- |
---- |
|
Unrestricted Funds |
Total Funds 2024 |
||
£ |
£ |
||
Current assets |
51,743 |
51,743 |
|
Creditors less than 1 year |
(24,217) |
(24,217) |
|
-------- |
-------- |
||
Net assets |
27,526 |
27,526 |
|
-------- |
-------- |
||
Unrestricted Funds |
Total Funds 2023 |
||
£ |
£ |
||
Current assets |
44,817 |
44,817 |
|
Creditors less than 1 year |
(17,765) |
(17,765) |
|
-------- |
-------- |
||
Net assets |
27,052 |
27,052 |
|
-------- |
-------- |
||